Multiple Sclerosis (MS) and Cannabinoids

Published: 30 June 2025
Last Updated: 24 July 2026
Last Reviewed: 24 July 2026
Author: Weed Supermarket Editorial Team

What Does Current Research Say?

Multiple Sclerosis (MS) is a lifelong neurological condition that affects the brain and spinal cord. Symptoms vary considerably between individuals and can change over time, making management highly personal.

As research into cannabinoids has expanded, increasing attention has focused on whether compounds such as CBD, THC and other cannabinoids may have a role in managing certain MS-related symptoms.

This article examines the current scientific evidence while distinguishing between approved medical treatments, prescription cannabis medicines and consumer cannabinoid products.

What Is Multiple Sclerosis?

Multiple Sclerosis is an autoimmune condition in which the body’s immune system mistakenly attacks the protective covering surrounding nerve fibres (myelin).

This disrupts communication between the brain and other parts of the body, resulting in a wide range of neurological symptoms.

Common symptoms include:

Muscle stiffness and spasticity.
Fatigue.
Nerve pain.
Mobility difficulties.
Balance problems.
Muscle weakness.
Visual disturbances.
Cognitive changes.

Symptoms differ greatly between individuals, and disease progression can vary considerably.

Current Treatment for MS

Management of Multiple Sclerosis often combines disease-modifying therapies with treatments aimed at controlling individual symptoms.

Depending on the person, treatment may include:

Disease-modifying medicines.
Physiotherapy.
Occupational therapy.
Pain management.
Medication for muscle spasticity.
Lifestyle and rehabilitation support.

These treatments remain the foundation of MS management under current UK clinical guidance.

Why Are Cannabinoids Being Studied?

Researchers have investigated cannabinoids because they interact with the body’s endocannabinoid system, which plays a role in pain perception, muscle function and nervous system signalling.

These biological pathways are relevant to several symptoms experienced by people living with MS.

However, research findings differ depending on the cannabinoid being studied and the specific symptom being assessed.

CBD and Multiple Sclerosis

CBD (cannabidiol) is a non-intoxicating cannabinoid that continues to be investigated for several neurological conditions.

Research has explored CBD in relation to:

Pain.
Inflammation.
Sleep.
Anxiety.
General wellbeing.

Although these areas are relevant to people living with MS, current evidence does not demonstrate that CBD alone is an established treatment for Multiple Sclerosis or that it slows disease progression.

Further high-quality clinical trials are needed.

Learn more in our guide explaining the CBD Entourage Effect.

Medical Cannabis and MS

Among neurological conditions, Multiple Sclerosis is one area where cannabis-based medicines have received considerable scientific attention.

In the UK, certain prescription cannabis-based medicinal products may be considered by specialist clinicians for managing treatment-resistant muscle spasticity in some people with MS.

These medicines are subject to strict prescribing criteria and should not be confused with consumer CBD products.

Muscle Spasticity

Muscle spasticity is one of the most studied MS symptoms in relation to cannabis-based medicines.

Clinical trials have shown that some prescription cannabis medicines containing cannabinoids may provide symptom relief for certain patients whose spasticity has not responded adequately to conventional treatment.

Responses vary between individuals, and treatment decisions remain the responsibility of specialist healthcare professionals.

Pain and Sleep

Researchers have also investigated cannabinoids for symptoms including pain and sleep disturbance associated with MS.

Although some studies have reported improvements in certain patients, results remain mixed, and evidence varies according to the specific cannabinoid formulation studied.

Current evidence does not support making broad claims that CBD products consistently relieve MS-related pain or improve sleep for everyone.

Can Cannabinoids Slow MS Progression?

Laboratory research has explored possible anti-inflammatory and neuroprotective properties of certain cannabinoids.

However, there is currently no convincing clinical evidence demonstrating that CBD or other cannabinoids slow the progression of Multiple Sclerosis in humans.

Research into this area remains ongoing.

Possible Side Effects and Interactions

Cannabinoids are not suitable for everyone.

Possible side effects or considerations include:

Drowsiness.
Dizziness.
Dry mouth.
Digestive discomfort.
Potential interactions with prescribed medicines.

Anyone living with MS should discuss cannabinoid use with their neurologist, MS nurse or GP before introducing new products.

Why Product Quality Matters

Independent laboratory testing provides information about the composition of cannabinoid products.

Testing may include:

Cannabinoid content.
THC concentration.
Heavy metals.
Residual solvents.
Microbiological contamination.
Batch consistency.

Testing helps verify product composition but does not demonstrate effectiveness for treating Multiple Sclerosis.

Read more in our UK Compliance & Laboratory Testing guide.

Related Guides

Frequently Asked Questions

Can CBD treat Multiple Sclerosis?

No. CBD has not been proven to treat or cure Multiple Sclerosis.

Is medical cannabis prescribed for MS in the UK?

In some circumstances, specialist clinicians may prescribe certain cannabis-based medicinal products for treatment-resistant muscle spasticity associated with MS.

Can CBD reduce muscle spasms?

Research has focused primarily on prescription cannabis medicines rather than consumer CBD products. Evidence relating to CBD alone remains limited.

Can cannabinoids slow MS progression?

Current clinical evidence does not demonstrate that cannabinoids slow the progression of Multiple Sclerosis.

Should I stop my MS medication if I use CBD?

No. Never stop prescribed treatment without discussing it with your healthcare team.

Can CBD interact with MS medication?

Yes. CBD may interact with certain medicines. Always seek medical advice before introducing cannabinoid products alongside prescribed treatment.

Final Thoughts

Multiple Sclerosis remains an active area of cannabinoid research, particularly regarding muscle spasticity, pain and quality of life.

Although prescription cannabis-based medicines may be appropriate for some carefully selected patients, current evidence does not support claims that consumer CBD products treat Multiple Sclerosis or alter the course of the disease.

Anyone considering cannabinoids should continue to work closely with their healthcare team while recognising that research continues to evolve.

Compliance Statement

This article is provided for educational purposes only and does not constitute medical advice. It does not claim that CBD, THC or other cannabinoids diagnose, treat, prevent or cure Multiple Sclerosis. Anyone living with MS should seek advice from their neurologist, MS nurse or other appropriately qualified healthcare professional before making changes to their treatment plan.